HGH Fragment 176-191 – 5mg (10 vials)

Product Overview

HGH Fragment 176-191 is a synthetic peptide based on a modified portion of the C-terminal region of human growth hormone (HGH). It has attracted research interest because of its relationship to growth hormone structure and investigations into lipid metabolism.

Unlike full-length human growth hormone, this fragment represents a much shorter peptide sequence and should not be described as equivalent to somatropin.

Scientific Background

Research involving HGH Fragment 176-191 has explored areas including:

• Peptide biology: Studied as a synthetic fragment derived from the structure of human growth hormone.
• Lipid metabolism: Investigated in experimental studies involving pathways associated with fat metabolism.
• Molecular signaling: Examined for its interactions with biological pathways related to growth hormone.
• Experimental research: Used in specialized investigations of peptide structure and biological activity.

These research interests do not establish proven fat-loss benefits or demonstrate safety and effectiveness in humans.

Product Specifications

• Product Name: HGH Fragment 176-191
• Listed Strength: 5mg
• Package Size: 10 vials
• Compound Classification: Synthetic peptide fragment
• Parent Protein: Human growth hormone
• Research Focus: Peptide biology and lipid metabolism

Product Information and Verification

Before publishing this listing, verify the exact peptide sequence, any modifications to the sequence, formulation, labeled strength, vial quantity, storage requirements, and supplier documentation.

Strength clarification: Confirm whether 5mg refers to each individual vial or the combined amount across all 10 vials. Ensure the product title accurately reflects the supplier’s labeling.

Do not make unsupported claims about purity, independent laboratory testing, certificates of analysis, fat reduction, or therapeutic effectiveness.

Safety and Regulatory Disclaimer

HGH Fragment 176-191 is an investigational peptide. Its safety and efficacy for human therapeutic use have not been established. It should not be presented as an approved medicine, a proven weight-loss treatment, or an equivalent alternative to authorized human growth hormone medicines.

Product labeling, advertising, and distribution must comply with applicable laws and regulations.

This description is provided for general scientific and educational purposes only and is not medical advice.